BTCYOTCSurgical & Medical Instruments & ApparatusFiscal year ends March 31
BIOTRICITY INC.
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026
$0.05+0.00 (+8.70%)
Close on Oct 19, 2026
- Market cap
- $1.15M
- P/E (TTM)
- –
- Dividend yield
- –
BIOTRICITY INC. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 81.5%
- Operating margin
- 9.6%
- Net margin
- -16.4%
- Return on equity, FY2026
- 7.2%
Financial strength
- Current ratio
- 0.15
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 1.2%
Valuation
- P/E ratio
- –
- Price to sales
- 0.07
- Price to book
- –
- Dividend yield
- –